Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Not yet open
Marker Therapeutics, Inc.
Phase 1
38
Texas
2026-07-16
By invitation
Adenocyte, LLC
Observational
500
New York
2024-10-15
Recruiting
Nammi Therapeutics Inc
Phase 1
100
California, Colorado, Georgia, New York, Texas, Wisconsin
2024-08-28
Recruiting
MOMA Therapeutics
Phase 1
220
Arizona, California, Florida, Missouri, New York, Pennsylvania, South Carolina, Tennessee
2024-08-13
Active, closed
DEKA Biosciences
Phase 1
39
California, New York, Oklahoma, Texas, Virginia
2023-04-03
Active, closed
Verastem, Inc.
Phase 1/2
40
California, Illinois, Massachusetts, Michigan, Missouri, New York, Pennsylvania, Utah
2023-03-22
Recruiting
Biological Dynamics
Observational
1,000
California
2022-12-19
Active, closed
TORL Biotherapeutics, LLC
Phase 1
163
California, Indiana, Missouri, Texas
2022-02-02
Active, closed
TORL Biotherapeutics, LLC
Phase 1
70
California, Indiana, Missouri
2022-01-20